Skip to main content
Erschienen in: Clinical and Translational Oncology 6/2014

01.06.2014 | Research Article

Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin

verfasst von: F. A. Calvo, F. Rivas, C. V. Sole, M. Gómez-Espí, R. Herranz, E. del Valle, M. Rodríguez, E. Álvarez

Erschienen in: Clinical and Translational Oncology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Anastomotic recurrence after radical sphincter-preserving surgery preceded by neoadjuvant therapy in locally advanced rectal cancer is an uncommon event that merits further assessment. The aim of this study is to analyze the effect of preoperative chemoradiation on the risk of anastomotic recurrence. Based on the initial extension of the tumor, we analyzed whether the distal surgical section was calculated through the virtual initial extension of the rectal tumor.

Patients and methods

Eligible patients with locally advanced rectal cancer were offered preoperative chemoradiation, sphincter sparing surgery and intraoperative radiation therapy boost.

Results

180 patients were treated with anterior resection (40 %), low anterior resection (45.6 %) and ultra-low anterior resection (14.4 %). With a median follow-up of 41.1 months (0.36–143 months), anastomotic recurrence was diagnosed in 9 patients (5 %). There was no statistical correlation with downstaging (T or N), downsizing effects, or with distance from the lower limit of the residual lesion to the distal margin. Virtual intratumoral surgical section was speculated in 44 patients (3 developed anastomotic recurrence; 6.8 vs 4.8 %, p = 0.482).

Conclusion

Anastomotic recurrence in patients with rectal cancer treated with neoadjuvant chemoradiation is an infrequent event. Virtual intratumoral surgical sections followed by anastomosis do not contribute to an excessive risk of recurrence. Our findings encourage the development of policies for preservation of the ano-rectal complex in rectal cancer patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet. 2001;358:1291–304.CrossRef Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet. 2001;358:1291–304.CrossRef
2.
Zurück zum Zitat Camma C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M. Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA. 2000;284:1008–15.PubMedCrossRef Camma C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M. Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA. 2000;284:1008–15.PubMedCrossRef
3.
Zurück zum Zitat Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010;36:470–6.PubMedCrossRef Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010;36:470–6.PubMedCrossRef
4.
Zurück zum Zitat Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620–5.PubMedCrossRef Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620–5.PubMedCrossRef
5.
Zurück zum Zitat Calvo FA, Serrano FJ, García Alonso P. Neoadyuvant oxaliplatin + 5-FU followed by chemo-radiation in rectal cancer. Post-resection p-stage, pT size and degree of histopathological residue. Proc Am Soc Clin Oncol 22;2003 (abstr 1359). Calvo FA, Serrano FJ, García Alonso P. Neoadyuvant oxaliplatin + 5-FU followed by chemo-radiation in rectal cancer. Post-resection p-stage, pT size and degree of histopathological residue. Proc Am Soc Clin Oncol 22;2003 (abstr 1359).
6.
Zurück zum Zitat Gavioli M, Losi L, Luppi G, Iacchetta F, Zironi S, Bertolini F, et al. Preoperative therapy for lower rectal cancer and modifications in distance from anal sphincter. Int J Radiat Oncol Biol Phys. 2007;69:370–5.PubMedCrossRef Gavioli M, Losi L, Luppi G, Iacchetta F, Zironi S, Bertolini F, et al. Preoperative therapy for lower rectal cancer and modifications in distance from anal sphincter. Int J Radiat Oncol Biol Phys. 2007;69:370–5.PubMedCrossRef
7.
Zurück zum Zitat Fiorica F, Cartei F, Licata A, Enea M, Ursino S, Colosimo C, et al. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data. Cancer Treat Rev. 2010;36:539–49.PubMedCrossRef Fiorica F, Cartei F, Licata A, Enea M, Ursino S, Colosimo C, et al. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data. Cancer Treat Rev. 2010;36:539–49.PubMedCrossRef
8.
Zurück zum Zitat Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, et al. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67:1381–8.PubMedCrossRef Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, et al. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67:1381–8.PubMedCrossRef
9.
Zurück zum Zitat Kusters M, Dresen RC, Martijn H, Nieuwenhuijzen GA, van de Velde CJ, van den Berg HA, et al. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2009;75:1444–9.PubMedCrossRef Kusters M, Dresen RC, Martijn H, Nieuwenhuijzen GA, van de Velde CJ, van den Berg HA, et al. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2009;75:1444–9.PubMedCrossRef
10.
Zurück zum Zitat Kusters M, Wallner C, Lange MM, DeRuiter MC, van de Velde CJ, Moriya Y, et al. Origin of presacral local recurrence after rectal cancer treatment. Br J Surg. 2010;97:1582–7.PubMedCrossRef Kusters M, Wallner C, Lange MM, DeRuiter MC, van de Velde CJ, Moriya Y, et al. Origin of presacral local recurrence after rectal cancer treatment. Br J Surg. 2010;97:1582–7.PubMedCrossRef
11.
Zurück zum Zitat Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, et al. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;71:1175–80.PubMedCrossRef Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, et al. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;71:1175–80.PubMedCrossRef
12.
Zurück zum Zitat Kusters M, Holman FA, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, et al. Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. Radiother Oncol. 2009;92:221–5.PubMedCrossRef Kusters M, Holman FA, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, et al. Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. Radiother Oncol. 2009;92:221–5.PubMedCrossRef
13.
Zurück zum Zitat Kusters M, Valentini V, Calvo FA, Krempien R, Nieuwenhuijzen GA, Martijn H, et al. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol. 2010;21:1279–84.PubMedCrossRef Kusters M, Valentini V, Calvo FA, Krempien R, Nieuwenhuijzen GA, Martijn H, et al. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol. 2010;21:1279–84.PubMedCrossRef
14.
Zurück zum Zitat Calvo FA, Gómez-Espí M, Díaz-González JA, Alvarado A, Cantalapiedra R, Marcos P, et al. Intraoperative presacral electron boost following preoperative chemora- diation in T3–4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiother Oncol. 2002;62:201–6.PubMedCrossRef Calvo FA, Gómez-Espí M, Díaz-González JA, Alvarado A, Cantalapiedra R, Marcos P, et al. Intraoperative presacral electron boost following preoperative chemora- diation in T3–4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiother Oncol. 2002;62:201–6.PubMedCrossRef
15.
Zurück zum Zitat Calvo FA, Gómez-Espí M, Díaz-González JA, Cantalapiedra R, Marcos P, Alvarado A, et al. Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur. Int J Radiat Oncol Biol Phys. 2001;51:1264–70.PubMedCrossRef Calvo FA, Gómez-Espí M, Díaz-González JA, Cantalapiedra R, Marcos P, Alvarado A, et al. Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur. Int J Radiat Oncol Biol Phys. 2001;51:1264–70.PubMedCrossRef
16.
Zurück zum Zitat Calvo FA, Serrano FJ, Diaz-González JA, Gomez-Espi M, Lozano E, Garcia R, et al. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. Ann Oncol. 2006;17:1103–10.PubMedCrossRef Calvo FA, Serrano FJ, Diaz-González JA, Gomez-Espi M, Lozano E, Garcia R, et al. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. Ann Oncol. 2006;17:1103–10.PubMedCrossRef
17.
Zurück zum Zitat Calvo FA, Santos A, Lozano MA. Early IORT experience in a public university hospital in Spain: hospital General Universitario Gregorio Maranon (Madrid). Front Radiat Ther Oncol. 1997;31:76–9.PubMedCrossRef Calvo FA, Santos A, Lozano MA. Early IORT experience in a public university hospital in Spain: hospital General Universitario Gregorio Maranon (Madrid). Front Radiat Ther Oncol. 1997;31:76–9.PubMedCrossRef
18.
Zurück zum Zitat Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a surveillance, epidemiology, and end results patterns-of-care study. Int J Radiat Oncol Biol Phys. 2011;80:978–84.PubMedCrossRef Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a surveillance, epidemiology, and end results patterns-of-care study. Int J Radiat Oncol Biol Phys. 2011;80:978–84.PubMedCrossRef
19.
Zurück zum Zitat Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer (review). Cochrane Database Syst Rev 2009;1:CD006041. Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer (review). Cochrane Database Syst Rev 2009;1:CD006041.
20.
Zurück zum Zitat Bosset JF, Collette L, Calais G, Mineur L, Maingon P. Radosevic-Jelic Let al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114–23.PubMedCrossRef Bosset JF, Collette L, Calais G, Mineur L, Maingon P. Radosevic-Jelic Let al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114–23.PubMedCrossRef
21.
Zurück zum Zitat Moureau-Zabotto L, Farnault B, de Chaisemartin C, Esterni B, Lelong B, Viret F, et al. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2011;80:483–91.PubMedCrossRef Moureau-Zabotto L, Farnault B, de Chaisemartin C, Esterni B, Lelong B, Viret F, et al. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2011;80:483–91.PubMedCrossRef
22.
Zurück zum Zitat Kim YW, Kim NK, Min BS, Huh H, Kim JS, Kim JY, et al. Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients. J Surg Oncol. 2009;99:58–64.PubMedCrossRef Kim YW, Kim NK, Min BS, Huh H, Kim JS, Kim JY, et al. Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients. J Surg Oncol. 2009;99:58–64.PubMedCrossRef
23.
Zurück zum Zitat Matsuda K, Hotta T, Takifuji K, Yokoyama S, Oku Y, Yamaue H. Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer. Langenbeck’s Arch Surg. 2010;395:235–9.CrossRef Matsuda K, Hotta T, Takifuji K, Yokoyama S, Oku Y, Yamaue H. Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer. Langenbeck’s Arch Surg. 2010;395:235–9.CrossRef
24.
Zurück zum Zitat Kusters M, Beets GL, van de Velde CJ, Beets-Tan RG, Marijnen CA, Rutten HJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009;249:229–35.PubMedCrossRef Kusters M, Beets GL, van de Velde CJ, Beets-Tan RG, Marijnen CA, Rutten HJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009;249:229–35.PubMedCrossRef
25.
Zurück zum Zitat de Chaisemartin C, Penna C, Goere D, Benoist S, Beauchet A, Julie C, et al. Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis. 2009;11:60–6.PubMedCrossRef de Chaisemartin C, Penna C, Goere D, Benoist S, Beauchet A, Julie C, et al. Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis. 2009;11:60–6.PubMedCrossRef
26.
Zurück zum Zitat den Dulk M, Marijnen CA, Collette L, Putter H, Påhlman L, Folkesson J, et al. Multicenter analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg. 2009;96:1066–7.CrossRef den Dulk M, Marijnen CA, Collette L, Putter H, Påhlman L, Folkesson J, et al. Multicenter analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg. 2009;96:1066–7.CrossRef
27.
Zurück zum Zitat Harris LJ, Phillips BR, Maxwell PJ, Isenberg GA, Goldstein SD. Outcomes of low anterior resection anastomotic leak after preoperative chemoradiation therapy for rectal cancer. Am Surg. 2010;76:747–51.PubMed Harris LJ, Phillips BR, Maxwell PJ, Isenberg GA, Goldstein SD. Outcomes of low anterior resection anastomotic leak after preoperative chemoradiation therapy for rectal cancer. Am Surg. 2010;76:747–51.PubMed
28.
Zurück zum Zitat Archampong D, Borowski DW, Dikinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52.PubMedCrossRef Archampong D, Borowski DW, Dikinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52.PubMedCrossRef
29.
Zurück zum Zitat Cantero-Muñoz P, Urién MA, Ruano-Ravina A. Efficacy and safety of intraoperative radiotherapy in colorectal cancer: a systematic review. Cancer Lett. 2011;306:121–33.PubMedCrossRef Cantero-Muñoz P, Urién MA, Ruano-Ravina A. Efficacy and safety of intraoperative radiotherapy in colorectal cancer: a systematic review. Cancer Lett. 2011;306:121–33.PubMedCrossRef
30.
Zurück zum Zitat Fietkau R, Barten M, Klautke G, Klar E, Ludwig K, Thomas H, et al. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum. 2006;49:1284–92.PubMedCrossRef Fietkau R, Barten M, Klautke G, Klar E, Ludwig K, Thomas H, et al. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum. 2006;49:1284–92.PubMedCrossRef
Metadaten
Titel
Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin
verfasst von
F. A. Calvo
F. Rivas
C. V. Sole
M. Gómez-Espí
R. Herranz
E. del Valle
M. Rodríguez
E. Álvarez
Publikationsdatum
01.06.2014
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 6/2014
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1119-9

Weitere Artikel der Ausgabe 6/2014

Clinical and Translational Oncology 6/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.